【中文】多肽药物的核心起始原料。年产数百吨氨基酸衍生物，产品质量全球领先；随着 GLP-1 类药物持续火热，其保护氨基酸产品已成为众多多肽药物制造商的核心供应商之选。
【English】The core starting materials for peptide pharmaceuticals. With an annual capacity of hundreds of tons and product quality ranking among the best worldwide, its protected amino acid products have become the preferred choice for numerous peptide drug developers as GLP-1 receptor agonists continue to surge.
